麻豆传媒

Findings may have implications for understanding other neurodegenerative diseases

25 drugs chosen so far comprise about a third of Medicare Part D spending on prescription drugs

Agency also issues final rule for 6-month buprenorphine prescriptions issued over the phone

Three drug approvals in a sample of 24 deviated from others

RNAi drug led to modest changes in disability, severity, and quality of life over 5 years

News and commentary from the world of neurology and neuroscience

Study results were neutral for periprocedural intra-arterial urokinase, tenecteplase

Radiation exposure, type and cumulative dose of chemotherapy drive melanoma risk

1 million adults projected to develop dementia each year by 2060

Randomized trial in China finds cognitive benefit, too

Clinical utility of the FDA-approved test isn't clear, researchers say

Florey Dementia Index leverages age and test scores

Device was recently approved for drug-refractory paroxysmal atrial fibrillation

Abrysvo and Arexvy labels will caution about risk of rare neurologic disorder